Technohal

prof.dr. S. Siesling (Sabine)

Full Professor
BMS-TPS-HTSR
Technohal 3105
s.siesling@utwente.nl
+31534895638
Business card

Sabine Siesling, clinical epidemiologist, is professor ‘Outcomes Research and Personalized cancer care’ at the University of Twente and senior researcher at the Netherlands Comprehensive Cancer Organisation (IKNL). She focusses on the effect of interventions, such as care pathways or implementation of new technologies, on the quality, organisation and outcome of cancer care. She tailors care and follow-up using/developing prediction models which are based on data from e.g. the Netherlands Cancer registry. She is board member of the National breast cancer working group (NABON) and the NABON Breast cancer audit and PROMS sections, and the European Initiative on Breast cancer Care-Quality assurance Development group. Moreover, she leads the program on Women’s Health at the University of Twente.  


She has been president of the Netherlands Epidemiological Society.  

Expertise

  • Medicine and Dentistry

    • Breast Cancer
    • Patient
    • Therapeutic Procedure
    • Survival
    • Cancer Registry
    • Neoplasm
    • Hospital
    • Malignant Neoplasm

Organisations

Ancillary activities

  • Integraal Kankercentrum Nederland (IKNL)headresearcher

Publications

2024

Adherence to guideline recommendations for follow-up in patients with DCIS at a large teaching hospital in the Netherlands (2024)Breast cancer research and treatment, 207(3), 633-640. Rajan, K. K., Nijveldt, J. J., Verheijen, S., Siesling, S., Beek, M. A. & Francken, A. B.https://doi.org/10.1007/s10549-024-07391-xFace and content validity of a holistic assessment questionnaire to assess cancer-related fatigue after breast cancer (2024)Fatigue: Biomedicine, Health and Behavior, 12(4), 293-307. Wijlens, K. A. E., Witteveen, A., Beenhakker, L., Siemerink, E. J. M., Achterkamp, R., Siesling, S., Vollenbroek-Hutten, M. M. R. & Bode, C.https://doi.org/10.1080/21641846.2024.238900770-Gene signature-guided adjuvant systemic treatment adjustments in early-stage ER+ breast cancer patients: 7-year follow-up of a prospective multicenter cohort study (2024)Breast cancer research and treatment (E-pub ahead of print/First online). Verreck, E. E. F., Kuijer, A., van Steenhoven, J. E. C., Volders, J. H., van der Velden, A. W. G., Siesling, S., Timmer-Bonte, A. N. H., Smilde, T. J., Imholz, A. L. T., Blanken-Peeters, C. F. J. M., de Valk, B., Vrijaldenhoven, S., Lastdrager, W. B., Haringhuizen, A. W., Hunting, J. C. B., Hovenga, S., Nieboer, P., Zuetenhorst, H. M., Tetteroo, G. W. M., … van Dalen, T.https://doi.org/10.1007/s10549-024-07496-3Surgical outcomes and prognosis of HER2+ invasive breast cancer patients with a DCIS component treated with breast-conserving surgery after neoadjuvant systemic therapy (2024)European journal of surgical oncology, 50(9). Article 108465. Ploumen, R. A. W., Claassens, E. L., Kooreman, L. F. S., Keymeulen, K., van Kats, M. A. C. E., van Kuijk, S. M. J., Siesling, S., van Nijnatten, T. J. A. & Smidt, M. L.https://doi.org/10.1016/j.ejso.2024.108465Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy (2024)JAMA Oncology, 10(8), 1077-1086. Geurts, V. c. m., Balduzzi, S., Steenbruggen, T. g., Linn, S. c., Siesling, S., Badve, S. s., Demichele, A., Ignatiadis, M., Leon-Ferre, R. a., Goetz, M. P., Wolff, A. c., Klar, N., Michiels, S., Loi, S., Adams, S., Horlings, H. m., Sonke, G. s., Salgado, R. & Kok, M.https://doi.org/10.1001/jamaoncol.2024.1917Symptom Monitoring and Health-Related Quality of Life in Non-metastatic Breast Cancer Patients: A Systematic Review (2024)Current Breast Cancer Reports, 16(4), 417-428 (E-pub ahead of print/First online). Vrancken Peeters, N. J. M. C., Koppert, L. B., Jager, A., Hendriks, M. P., Siesling, S. & van den Hurk, C. J. G.https://doi.org/10.1007/s12609-024-00562-1Een korte, praktische vragenlijst voor borstkankerpatiënten in de klinische praktijk: een aanpassing van de NABON MiniPROM (2024)Nederlands Tijdschrift voor Oncologie, 21, 45-50 (Accepted/In press). De Rooij, B. H., de Ligt, K., Verloop, J., Ezendam, N. P. M., Honkoop, A., Boersma, L. J., Schlooz-Vries, M., Siesling, S., Bessems, M. & Zeestraten, E.A comparison of treatment allocation and survival between younger and older patients with HER2-overexpressing de novo metastatic breast cancer (2024)Journal of geriatric oncology, 15(6). Article 101805. Lemij, A., de Glas, N., Kroep, J., Siesling, S., van den Bos, F., Bastiaannet, E., Liefers, G. J. & Portielje, J.https://doi.org/10.1016/j.jgo.2024.101805High-value breast cancer care within resource limitations (2024)Oncologist, 29(7), e899-e909. Verhoeven, D., Siesling, S., Allemani, C., Roy, P., Travado, L., Bhoo-Pathy, N., Rhayns, C., Junkermann, H., Nakamura, S., Lasebikan, N. & Tucker, F.https://doi.org/10.1093/oncolo/oyae080Implementation of ultra-hypofractionated radiotherapy schedules for breast cancer during the COVID-19 pandemic in the Netherlands (2024)Clinical and Translational Radiation Oncology, 47. Article 100807. Eijkelboom, A. H., Stam, M. R., van den Bongard, D. H. J. G., Sattler, M. G. A., Bantema-Joppe, E. J., Siesling, S. & van Maaren, M. C.https://doi.org/10.1016/j.ctro.2024.100807Information and communication priorities of patients and healthcare professionals in shared decision making regarding adjuvant systemic breast cancer treatment: A survey study (2024)European journal of oncology nursing, 70. Article 102574. Damman, O. C., van Strien-Knippenberg, I. S., Engelhardt, E. G., Determann, D., Bruijne, M. C. D., Siesling, S., Konings, I. R. & Timmermans, D. R. M.https://doi.org/10.1016/j.ejon.2024.102574Internal Responsiveness of EQ-5D-5L and EORTC QLQ-C30 in Dutch Breast Cancer Patients during the First Year Post-Surgery: A Longitudinal Cohort Study (2024)Cancers, 16(11), 1952. Article 1952. Vrancken Peeters, N. J. M. C., van Til, J. A., Huberts, A. S., Siesling, S., Husson, O. & Koppert, L. B.https://doi.org/10.3390/cancers16111952Opportunities for personalised follow-up in breast cancer: the gap between daily practice and recurrence risk (2024)Breast cancer research and treatment, 205, 313-322. Voets, M., Hassink, N., Veltman, J., Slump, C. H., Koffijberg, H. & Siesling, S.https://doi.org/10.1007/s10549-024-07246-5Continuity of care for patients with de novo metastatic cancer during the COVID-19 pandemic: A population-based observational study (2024)International journal of cancer, 154(10), 1786-1793. Slotman, E., Weijzen, F., Fransen, H. P., van Hoeve, J. C., Huijben, A. M. T., Kuip, E. J. M., Jager, A., Kunst, P. W. A., van Laarhoven, H. W. M., Tol, J., Tjan-Heijnen, V. C. G., Raijmakers, N. J. H., van der Linden, Y. M. & Siesling, S.https://doi.org/10.1002/ijc.34857The INFLUENCE 3.0 model: updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy (2024)[Working paper › Preprint]. Research Square Publications. van Maaren, M. C., Hueting, T. A., van Uden, D. J. P., van Hezewijk, M., de Munck, L., Mureau, M. A. M., Seegers, P. A., Voorham, Q. J., Schmidt, M. K., Sonke, G. S., Oudshoorn, C. G. M. & Siesling, S.https://doi.org/10.21203/rs.3.rs-4304136/v1The effectiveness of personalised surveillance and aftercare in breast cancer follow-up: a systematic review (2024)Supportive care in cancer, 32. Article 323. van Maaren, M. C., van Middelkoop-van Hoeve, J. C., Korevaar, J. C., van Hezewijk, M., Siemerink, E. J. M., Zeillemaker, A. M., Klaassen-Dekker, A., van Uden, D. J. P., Volders, J. H., Drossaert, S. C. H. C. & Siesling, S.https://doi.org/10.1007/s00520-024-08530-2ASO Author Reflections: What Can Prediction Models for Upstaging of DCIS Diagnosed on Biopsy Tell Us About DCIS Surveillance Trials? (2024)Annals of surgical oncology, 31(4), 2272-2273. Westenend, P., Meurs, C., van Bekkum, S., van Rosmalen, J., Menke-Pluijmers, M. & Siesling, S.https://doi.org/10.1245/s10434-024-14964-zKrebsregistrierung in Europa (2024)Die Onkologie, 30(4), 245-256. Arndt, V. & Siesling, S.https://doi.org/10.1007/s00761-023-01454-2Prognostic effect of nodal status before and after neoadjuvant chemotherapy in breast cancer: a Dutch population-based study (2024)Breast cancer research and treatment, 204, 277-288. de Wild, S. R., Koppert, L. B., de Munck, L., Vrancken Peeters, M. J. T. F. D., Siesling, S., Smidt, M. L. & Simons, J. M.https://doi.org/10.1007/s10549-023-07178-6Radiotherapy treatment patterns in the Netherlands: Insights from the Netherlands Cancer Registry (2024)[Thesis › PhD Thesis - Research external, graduation UT]. University of Twente. Evers, J.https://doi.org/10.3990/1.9789036560535

Research profiles

Scan the QR code or
Download vCard